Influenza vaccines: Unmet needs and recent developments

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Influenza is a worldwide public health concern. Since the introduction of trivalent influenza vaccine in 1978, vaccination has been the primary means of prevention and control of influenza. Current influenza vaccines have moderate efficacy, good safety, and acceptable tolerability; however, they have unsatisfactory efficacy in older adults, are dependent on egg supply for production, and are time-consuming to manufacture. This review outlines the unmet medical needs of current influenza vaccines. Recent developments in influenza vaccines are also described.

Original languageEnglish
Pages (from-to)375-386
Number of pages12
JournalInfection and Chemotherapy
Volume45
Issue number4
DOIs
Publication statusPublished - 2013 Dec 1

Fingerprint

Influenza Vaccines
Human Influenza
Primary Prevention
Ovum
Vaccination
Public Health
Safety

Keywords

  • Human
  • Influenza
  • Influenza vaccines
  • Pandemics

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Influenza vaccines : Unmet needs and recent developments. / Noh, Ji Yun; Kim, Woo Joo.

In: Infection and Chemotherapy, Vol. 45, No. 4, 01.12.2013, p. 375-386.

Research output: Contribution to journalReview article

@article{c9a90a9df0e043b0b83a3f825ddded99,
title = "Influenza vaccines: Unmet needs and recent developments",
abstract = "Influenza is a worldwide public health concern. Since the introduction of trivalent influenza vaccine in 1978, vaccination has been the primary means of prevention and control of influenza. Current influenza vaccines have moderate efficacy, good safety, and acceptable tolerability; however, they have unsatisfactory efficacy in older adults, are dependent on egg supply for production, and are time-consuming to manufacture. This review outlines the unmet medical needs of current influenza vaccines. Recent developments in influenza vaccines are also described.",
keywords = "Human, Influenza, Influenza vaccines, Pandemics",
author = "Noh, {Ji Yun} and Kim, {Woo Joo}",
year = "2013",
month = "12",
day = "1",
doi = "10.3947/ic.2013.45.4.375",
language = "English",
volume = "45",
pages = "375--386",
journal = "Infection and Chemotherapy",
issn = "2093-2340",
publisher = "Taehan Kamyom Hakhoe, Taehan Hwahak Yopop Hakhoe",
number = "4",

}

TY - JOUR

T1 - Influenza vaccines

T2 - Unmet needs and recent developments

AU - Noh, Ji Yun

AU - Kim, Woo Joo

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Influenza is a worldwide public health concern. Since the introduction of trivalent influenza vaccine in 1978, vaccination has been the primary means of prevention and control of influenza. Current influenza vaccines have moderate efficacy, good safety, and acceptable tolerability; however, they have unsatisfactory efficacy in older adults, are dependent on egg supply for production, and are time-consuming to manufacture. This review outlines the unmet medical needs of current influenza vaccines. Recent developments in influenza vaccines are also described.

AB - Influenza is a worldwide public health concern. Since the introduction of trivalent influenza vaccine in 1978, vaccination has been the primary means of prevention and control of influenza. Current influenza vaccines have moderate efficacy, good safety, and acceptable tolerability; however, they have unsatisfactory efficacy in older adults, are dependent on egg supply for production, and are time-consuming to manufacture. This review outlines the unmet medical needs of current influenza vaccines. Recent developments in influenza vaccines are also described.

KW - Human

KW - Influenza

KW - Influenza vaccines

KW - Pandemics

UR - http://www.scopus.com/inward/record.url?scp=84893172926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893172926&partnerID=8YFLogxK

U2 - 10.3947/ic.2013.45.4.375

DO - 10.3947/ic.2013.45.4.375

M3 - Review article

AN - SCOPUS:84893172926

VL - 45

SP - 375

EP - 386

JO - Infection and Chemotherapy

JF - Infection and Chemotherapy

SN - 2093-2340

IS - 4

ER -